Skip to content
College of Public Affairs

Previous Rosenberg Dialogue Series Sessions

Dig a little deeper into what we've discussed in the past.

  • Rosenberg fall 15
    FALL 2015

    Cybersecurity: Is Patient Privacy Extinct?
    Lessons Learned for Secure, Reliable Public-Private Systems

    Privacy breaches to electronic health records and related financial data are happening faster and more frequently than ever. Recently, a breach at a major provider gave unauthorized access to the personal health information of 78.8 million. In light of this and other disturbing developments in the realm of health care privacy, academic and public- and private sector experts led an interactive and in-depth discussion about patient privacy, discussing the issue as it relates to the interaction between public-sector laws and private-sector initiatives and offering insight into lessons learned and next steps.

    Kirk Grothe, CEO, Livanta
    Charles Tumosa, professor of the practice in the School of Criminal Justice at the University of Baltimore

  • Rosenberg spr 13
    SPRING 2013

    Public-Private Partnerships in an Age of Austerity: State-Local and Federal-State Dynamics

    The Rosenberg Dialogue Series explores opportunities for the private sector to work in partnership with the public and nonprofit (nongovernmental organization) sectors to create a vibrant and economically strong society. This dialogue delves into how federalism and intergovernmental relations influence the type and extent of such partnerships.

    John Callahan, executive in residence and program director, UB College of Public Affairs, School of Health and Human Services
    John Willis, executive in residence, UB College of Public Affairs, School of Public and International Affairs

  • Rosenberg fall 12
    FALL 2012

    Maryland Hospitals and Environmental Sustainability: Green Health-Care Facilities

    Health care is a vital component of Maryland's economy, but health-care facilities face many worksite and environmental challenges. Economic, social and environmental health impacts of energy consumption; water usage; material purchase, use and wastage; as well as the quantity and toxicity of the chemicals used in and for health care must be managed concurrently.

    For health-care providers, there is also a moral imperative—an ethical obligation—to create a resilient health-care system that benefits citizens as well as organized stakeholders. Achieving this balance within resource constraints requires management efficiency, operational effectiveness, cost containment while maintaining quality of care, and ensuring employees' health, general safety and environmental sustainability.

    How can these goals be achieved affordably and reliably? What are the opportunities for public-private-sector collaboration?

    Joan Plisko, technical director, Maryland Hospitals for a Healthy Environment
    Clifford Mitchell, director, Environmental Health Bureau, Prevention and Health Promotion Administration, Maryland Department of Health and Mental Hygiene

  • Rosenberg spr 12
    SPRING 2012

    Access to Pharmaceutical Products and Services for Underserved Populations: Public- and Private-Sector Roles in the United States and India

    The front line of our public health system is not a doctor's office, an emergency room or even a clinic, but our local pharmacies. The community pharmacist is the first and often most frequent point of contact that many people have with the organized health-care system. Medicine shortages are the most visible consequence of a changed and interconnected world, but underserved populations confront unmet needs for access to pharmacist services and clinical information.

    Education for community pharmacists' clinical roles continues to require significant curricular change and mentored experiential education. This has led to an undersupply of pharmacists globally, with implications for unmet medical needs and avoidable drug interactions that manifest in other areas of the health-care system: crisis visits to emergency rooms; hospitalizations; and secondary, perhaps chronic, disabilities.

    Magaly Rodriguez de Bittner, professor and chair, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy
    Anne Y.F. Lin, dean, School of Pharmacy, Notre Dame of Maryland University
    Prasada Reddy, pharmacist, Taastrup Apotek, Copenhagen area, Denmark; Tamil Nadu Dr. M.G.R. Medical University; RMES's College of Pharmacy